Global Electrophysiology Mapping and Ablation Devices Market, By Type (Conventional, Advanced, Ultrasound, Ablation Catheters), Application (Atrial Fibrillation (AF), Premature Ventricular Contractions (PVC), Atrioventricular Nodal Re-Entry Tachycardia (AVNRT), Wolff-Parkinson-White Syndrome (WFW), Atrial Flutterr, AV Re-Entrant Tachycardia, AV Nodal Tachycardia, Others), End User (Hospitals, Diagnostic Centres, Clinics and Others) - Industry Trends and Forecast to 2030.
Electrophysiology Mapping and Ablation Devices Market Analysis and Size
Electrophysiology mapping and ablation devices refer to the market for medical devices used in the diagnosis and treatment of cardiac arrhythmias and related conditions. Electrophysiology mapping devices are used to create a visual representation of the electrical activity of the heart, while ablation devices are used to correct abnormal electrical pathways through the application of controlled energy.
Data Bridge Market Research analyses that the electrophysiology mapping and ablation devices market was valued at USD 5678.98 million in 2022 and is expected to reach the value of USD 8745.21 million by the year 2030, at a CAGR of 8.86% during the forecast period. This indicates the market value. “Conventional” dominates the type segment of the electrophysiology mapping and ablation devices market owing to the increasing prevalence of cardiac arrhythmias. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Electrophysiology Mapping and Ablation Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Conventional, Advanced, Ultrasound and Ablation Catheters), Application (Atrial Fibrillation (AF), Premature Ventricular Contractions (PVC), Atrioventricular Nodal Re-Entry Tachycardia (AVNRT), Wolff-Parkinson-White Syndrome (WFW), Atrial Flutterr, AV Re-Entrant Tachycardia, AV Nodal Tachycardia and Others), End User (Hospitals, Diagnostic Centres, Clinics and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
|
|
Market Players Covered
|
Acutus Medical, Inc. (U.S.), ATRICURE, INC (U.S.), Abbott (U.S.), Boston Scientific Corporation (U.S.), Biosense Webster, Inc. (U.S.), Medtronic (Ireland), Auris Health, Inc. (U.S.), Stereotaxis, Inc. (U.S.), GENERAL ELECTRIC COMPANY (U.S.), Koninklijke Philips N.V. (Netherlands), Siemens Healthcare GmbH (Germany), MicroPort Scientific Corporation (China), BIOTRONIK SE & Co KG (Germany), NIHON KOHDEN CORPORATION (Japan), Imricor (U.S.), EP Solutions. (Czech Republic), EPMap-System GmbH (Germany) among others.
|
|
Market Opportunities
|
|
Market Definition
Electrophysiology mapping and ablation devices are those medical devices that are used map out and differentiate the healthy and unhealthy tissues of the heart. In other words, electrophysiology mapping and ablation devices are used especially for electrophysiology procedures. The electrophysiology mapping and ablation devices are used for both diagnosis and treatment purposes.
Global Electrophysiology Mapping and Ablation Devices Market Dynamics
Drivers
- Increasing Prevalence of Cardiac Arrhythmias
The rising incidence of cardiac arrhythmias, including atrial fibrillation, ventricular tachycardia, and atrioventricular nodal reentry tachycardia, is a major driver for the market. As the global population ages and the prevalence of risk factors such as obesity and hypertension increases, the demand for electrophysiology mapping and ablation devices is expected to grow.
- Technological Advancements
Advances in electrophysiology mapping and ablation technologies have significantly improved the accuracy and efficacy of procedures. The development of high-resolution mapping systems, real-time imaging technologies, and contact force sensing catheters have enhanced the precision of diagnosis and treatment, driving market growth.
- Growing Awareness and Treatment-seeking Behavior
Increasing awareness about the available treatment options for cardiac arrhythmias and improved access to healthcare facilities have resulted in higher patient volumes seeking electrophysiology procedures. Patients are now more likely to seek treatment for symptoms such as palpitations, shortness of breath, and fatigue, thereby boosting the demand for mapping and ablation devices.
Opportunities
The government initiatives, schemes, or funding that support and promotes the innovation and development of the Electrophysiology mapping and ablation devices market provide growth opportunities for the market players in the forecast period of 2023 to 2030. Additionally, emerging markets, increasing research and development activities, penetration rate, market expansion in developing countries, integration of artificial intelligence and machine learning methods globally and increasing per capita expenditure on health care will further expand the market's growth rate in the future.
Restraints
High Cost of Devices and Procedures
Electrophysiology mapping and ablation devices are often expensive, and the associated procedures can be financially burdensome for patients. The high cost of devices, coupled with the need for skilled healthcare professionals and specialized facilities, can limit the adoption of these devices, especially in developing regions.
Challenges
Integration of Artificial Intelligence (AI) and Machine Learning (ML)
The integration of AI and ML algorithms in electrophysiology mapping and ablation devices can enhance the accuracy of diagnosis and treatment. These technologies can provide real-time data analysis, predictive analytics, and personalized treatment recommendations, opening new avenues for innovation and market growth. Also, risk stratification and patient management among healthcare providers in developing economies, adherence to lifestyle modifications and medications, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2023-2030.
This electrophysiology mapping and ablation devices market report provide details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Electrophysiology mapping and ablation devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- According to the American Heart Association, by 2030, about 41.4% of US adults will have hypertension (an increase of 8.4% from 2012). The organization also estimates that the global cost of CVD will reach USD 1,044 billion by 2030 from USD 863 billion in 2010.
Global Electrophysiology Mapping and Ablation Devices Market Scope
The electrophysiology mapping and ablation devices market is segmented on the basis of type, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Conventional
- Advanced
- Ultrasound
- Ablation Catheters
Application
- Atrial Fibrillation (AF)
- Premature Ventricular Contractions (PVC)
- Atrioventricular Nodal Re-Entry Tachycardia (AVNRT)
- Wolff-Parkinson-White Syndrome (WFW)
- Atrial Flutter
- AV Re-Entrant Tachycardia
- AV Nodal Tachycardia
- Others
End User
- Hospitals
- Diagnostic Centres
- Clinics
- Others
Global Electrophysiology Mapping and Ablation Devices Market Regional Analysis/Insights
The electrophysiology mapping and ablation devices market is analysed and market size insights and trends are provided by country, type, application and end user as referenced above.
The countries covered in the electrophysiology mapping and ablation devices market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America is expected to dominate the electrophysiology mapping and ablation devices market because of the increasing prevalence of cardiac arrests and heart failures. Asia-Pacific, on the other hand, is projected to exhibit the highest growth rate during the forecast period owing to the rising research and development proficiencies and rapidly growing incidence rates of target diseases.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the huge patient population and rise in the presence of huge opportunities in the market in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The electrophysiology mapping and ablation devices market also provide you with detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for electrophysiology mapping and ablation devices market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the Electrophysiology mapping and ablation devices market. The data is available for the historic period 2015-2020.
Competitive Landscape and Electrophysiology Mapping and Ablation Devices Market Share Analysis
The electrophysiology mapping and ablation devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the electrophysiology mapping and ablation devices market.
Some of the major players operating in the electrophysiology mapping and ablation devices market are:
- Acutus Medical, Inc. (U.S.)
- ATRICURE, INC (U.S.)
- Abbott (U.S.)
- Boston Scientific Corporation (U.S.)
- Biosense Webster, Inc. (U.S.)
- Medtronic (Ireland)
- Auris Health, Inc. (U.S.)
- Stereotaxis, Inc. (U.S.)
- GENERAL ELECTRIC COMPANY (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- Siemens Healthcare GmbH (Germany)
- MicroPort Scientific Corporation (China)
- BIOTRONIK SE & Co KG (Germany)
- NIHON KOHDEN CORPORATION (Japan)
- Imricor (U.S.)
- EP Solutions. (Czech Republic)
- EPMap-System GmbH (Germany
SKU-